title: Application of traditional Chinese medicine injection in treatment of primary liver cancer: a review.
abstract: OBJECTIVE
  To investigate the application of Traditional Chinese Medicine Injections (TCMIs) for treatment of primary liver cancer (PLC).
  
  
  METHODS
  A literature review was conducted using PubMed/Medline, Cochrane Library Controlled Clinical Trials Database, China National Knowledge Infrastructure (CNKI), China Scientific Journal Database (CSJD) and China Biology Medicine (CBM). Online websites including journal websites and databases of ongoing trials, as well as some Traditional Chinese Medicine journals that are not indexed in the electronic databases were also searched. as adjunctive medication for the treatment of PLC could regulate patient immunity, reduce bone marrow suppression, relieve clinical symptoms, and improve quality of life, as well as control disease progression and prolong survival time.
  
  
  CONCLUSIONS
  Within the limitations of this review, we conclude that application of TCMIs as adjunctive medication may provide benefits for patients with PLC. Further large, high-quality trials are warranted.
authors.affiliation: Department of Traditional Chinese Medicine, Changhai Hospital, Second Military Medical University, Shanghai 200433, China.
authors.forename: Mouduo
authors.initials: M
authors.lastname: Li
authors.forename: Cuixia
authors.initials: C
authors.lastname: Qiao
authors.forename: Liping
authors.initials: L
authors.lastname: Qin
authors.forename: Junyong
authors.initials: J
authors.lastname: Zhang
authors.forename: Changquan
authors.initials: C
authors.lastname: Ling
mesh_terms: D003131:Combined Modality Therapy; D004365:Drugs, Chinese Herbal / Q000008:administration & dosage*; D006801:Humans; D007267:Injections; D008113:Liver Neoplasms / Q000188:drug therapy* / Q000532:radiotherapy / Q000601:surgery
chemical_list: D004365:Drugs, Chinese Herbal